Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment
- PMID: 12127793
- DOI: 10.1006/viro.2002.1497
Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment
Abstract
We have examined the consequences of cleaving the fusion glycoprotein (F) of human respiratory syncytial virus (HRSV) at two distinct furin-recognition sites. Purified anchorless F is a mixture of unaggregated cone-shaped molecules and rosettes of lollipop-shaped spikes. The unaggregated molecules contain a proportion of uncleaved F0 and an intermediate, F(delta1-109), cleaved only at site I, residues 106-109. Inhibition of cleavage at site I, by two amino acid changes (R108N/R109N), reduces the proportion of aggregated molecules with a concomitant increase in the amount of unprocessed F0. Inhibition of cleavage at site II, residues 131-136, by deletion of four amino acids (delta131-134), abrogates aggregation of anchorless F and all molecules are seen as individual cone-shaped rods. In vitro cleavage of anchorless F, or mutant delta131-134, with trypsin at 4, 20, or 37 degrees C, under conditions in which cleavage at site II is complete in all molecules, leads to their aggregation in rosettes of lollipop-shaped spikes. Thus, cleavage at site II is required for the structural changes in anchorless F that lead to changes in shape and to aggregation. The segment between sites I and II, residues 110-136, is not associated with anchorless F in the supernatant of infected cell cultures, indicating that it is released from the processed protein when cleavage at sites I and II is completed.
Similar articles
-
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion.Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9859-64. doi: 10.1073/pnas.151098198. Epub 2001 Aug 7. Proc Natl Acad Sci U S A. 2001. PMID: 11493675 Free PMC article.
-
Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism.J Gen Virol. 2004 Dec;85(Pt 12):3677-3687. doi: 10.1099/vir.0.80318-0. J Gen Virol. 2004. PMID: 15557241
-
Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences.J Biol Chem. 2001 Aug 24;276(34):31642-50. doi: 10.1074/jbc.M102633200. Epub 2001 Jun 19. J Biol Chem. 2001. PMID: 11418598
-
Functional analysis of the N-linked glycans within the fusion protein of respiratory syncytial virus.Methods Mol Biol. 2007;379:69-83. doi: 10.1007/978-1-59745-393-6_5. Methods Mol Biol. 2007. PMID: 17502671 Review.
-
The use of two-dimensional SDS-PAGE to analyze the glycan heterogeneity of the respiratory syncytial virus fusion protein.Methods Mol Biol. 2007;379:97-108. doi: 10.1007/978-1-59745-393-6_7. Methods Mol Biol. 2007. PMID: 17502673 Review.
Cited by
-
Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics.PLoS One. 2015 Jun 24;10(6):e0130829. doi: 10.1371/journal.pone.0130829. eCollection 2015. PLoS One. 2015. PMID: 26107504 Free PMC article.
-
Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity.Vaccines (Basel). 2020 Oct 14;8(4):607. doi: 10.3390/vaccines8040607. Vaccines (Basel). 2020. PMID: 33066540 Free PMC article.
-
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9619-24. doi: 10.1073/pnas.1106536108. Epub 2011 May 17. Proc Natl Acad Sci U S A. 2011. PMID: 21586636 Free PMC article.
-
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein.PLoS Pathog. 2015 Jul 10;11(7):e1005035. doi: 10.1371/journal.ppat.1005035. eCollection 2015 Jul. PLoS Pathog. 2015. PMID: 26161532 Free PMC article.
-
Immunogenicity of a recombinant plant-produced respiratory syncytial virus F subunit vaccine in mice.Biotechnol Rep (Amst). 2023 Dec 23;41:e00826. doi: 10.1016/j.btre.2023.e00826. eCollection 2024 Mar. Biotechnol Rep (Amst). 2023. PMID: 38234330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources